
NeuWire Medical Receives FDA IDE Approval for STROKE-REWIRE Pivotal Study in Chronic Ischemic Stroke
NeuWire Medical Announces FDA IDE Approval for STROKE-REWIRE Pivotal Study in Chronic Ischemic Stroke NeuWire Medical announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application for STROKE-REWIRE, a pivotal study evaluating the…














